Validation of Academic Research Consortium for High Bleeding Risk Definition in East-Asian Patients

BACKGROUND: Clinical applicability of the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in East-Asian patients receiving potent antiplatelet therapy for acute coronary syndromes (ACS) is still undetermined. OBJECTIVES: The purpose of this study was to validate the ARC definition...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jinho, Kim, Min-Ju, Kim, Mijin, Park, Jinsun, Kim, Hoyun, Cho, Suji, Choi, Yeonwoo, Lee, Junghoon, Kim, Ju Hyeon, Cha, Sung Joo, Kim, Tae Oh, Kang, Do-Yoon, Lee, Pil Hyung, Ahn, Jung-Min, Park, Seung-Jung, Park, Duk-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261889/
https://www.ncbi.nlm.nih.gov/pubmed/37323862
http://dx.doi.org/10.1016/j.jacasi.2022.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261889/
https://www.ncbi.nlm.nih.gov/pubmed/37323862
http://dx.doi.org/10.1016/j.jacasi.2022.11.012

Ejemplares similares